Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Corcept Therapeutics (CORT) Cash from Financing Activities (2016 - 2026)

Corcept Therapeutics (CORT) has disclosed Cash from Financing Activities for 15 consecutive years, with $760000.0 as the latest value for Q1 2026.

  • For Q1 2026, Cash from Financing Activities rose 101.91% year-over-year to $760000.0; the TTM value through Mar 2026 reached -$179.8 million, down 165.95%, while the annual FY2025 figure was -$220.4 million, 677.33% down from the prior year.
  • Cash from Financing Activities hit $760000.0 in Q1 2026 for Corcept Therapeutics, up from -$31.2 million in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $766000.0 in Q4 2023 and bottomed at -$145.8 million in Q2 2023.
  • Average Cash from Financing Activities over 5 years is -$24.4 million, with a median of -$3.9 million recorded in 2023.
  • Year-over-year, Cash from Financing Activities soared 1355.74% in 2023 and then plummeted 7230.2% in 2025.
  • Corcept Therapeutics' Cash from Financing Activities stood at -$61000.0 in 2022, then skyrocketed by 1355.74% to $766000.0 in 2023, then crashed by 695.82% to -$4.6 million in 2024, then tumbled by 583.96% to -$31.2 million in 2025, then soared by 102.43% to $760000.0 in 2026.
  • According to Business Quant data, Cash from Financing Activities over the past three periods came in at $760000.0, -$31.2 million, and -$46.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.